Covered recipient · General Payments record
CALVIN E BECK
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,654.53
- Reported across 193 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $486.11 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $152.84 | 9 |
| ABBVIE INC. | $114.06 | 6 |
| Acerta Pharma LLC | $60.88 | 4 |
| PFIZER INC. | $39.24 | 2 |
| Lilly USA, LLC | $38.56 | 2 |
| Nevro Corp. | $24.19 | 1 |
| Amgen Inc. | $19.47 | 1 |
| DEXCOM, INC. | $19.47 | 1 |
| GlaxoSmithKline, LLC. | $17.40 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.03 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103297004 | CMS |
| ABBVIE INC. | $21.79 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103297006 | CMS |
| ABBVIE INC. | $24.17 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103297008 | CMS |
| ABBVIE INC. | $14.72 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103297010 | CMS |
| ABBVIE INC. | $15.68 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103297012 | CMS |
| ABBVIE INC. | $17.67 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103297014 | CMS |
| Amgen Inc. | $19.47 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111526762 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.16 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104509176 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.98 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104543516 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.27 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105244787 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.47 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104312060 | CMS |
| Dexcom, Inc. | $19.47 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153289633 | CMS |
| GlaxoSmithKline, LLC. | $17.40 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116260071 | CMS |
| Lilly USA, LLC | $23.92 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136082952 | CMS |
| Lilly USA, LLC | $14.64 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136083998 | CMS |
| Nevro Corp. | $24.19 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130768024 | CMS |
| Novo Nordisk Inc | $17.55 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097619561 | CMS |
| Novo Nordisk Inc | $17.71 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097440021 | CMS |
| Novo Nordisk Inc | $17.55 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097668681 | CMS |
| Novo Nordisk Inc | $6.16 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097031814 | CMS |
| Novo Nordisk Inc | $19.48 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096626321 | CMS |
| Novo Nordisk Inc | $17.56 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097711558 | CMS |
| Novo Nordisk Inc | $17.25 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096594802 | CMS |
| Novo Nordisk Inc | $22.02 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096976210 | CMS |
| Novo Nordisk Inc | $17.56 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096933705 | CMS |
| PFIZER INC. | $16.11 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131642462 | CMS |
| PFIZER INC. | $23.13 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131668541 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.